MIT Technology Review
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…
有活动行业的新闻要分享吗?
提交新闻稿或信息,触达数千名活动行业专业人士。